{"id":330305,"date":"2026-10-28T12:38:59","date_gmt":"2026-10-28T07:08:59","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=330305"},"modified":"2026-10-28T12:38:59","modified_gmt":"2026-10-28T07:08:59","slug":"research-led-drug-maker-branded-formulations-company-and-finished-dosage-generics-manufacturer-stocks-roadmap-nimbus-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/research-led-drug-maker-branded-formulations-company-and-finished-dosage-generics-manufacturer-stocks-roadmap-nimbus-list\/","title":{"rendered":"3 Research Led Drug Maker, Branded Formulations Company and Finished Dosage Generics Manufacturer Stocks With a Strong Future Roadmap: Glenmark Pharmaceuticals, JB Chemicals and Pharmaceuticals and Strides Pharma Science"},"content":{"rendered":"

Glenmark Pharmaceuticals, JB Chemicals and Pharmaceuticals and Strides Pharma Science: ROE of 17.1% to 28.1% and FY22 to FY26 revenue CAGR of 8.7% to 14.3%. Prices as of 27 Oct 2026.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

The three innovation led and generic pharma stocks to watch are Glenmark Pharmaceuticals, JB Chemicals and Pharmaceuticals and Strides Pharma Science. Their return on equity ranges from 17.1% to 28.1%, and their revenue compound annual growth from FY22 to FY26 ranges from 8.7% to 14.3%. Glenmark Pharmaceuticals has the highest return on equity at 28.1%, while JB Chemicals and Pharmaceuticals has the fastest revenue growth at 14.3% a year. Prices are based on the 27 October 2026 close, and this article is educational, not investment advice.<\/p>\n<\/div>\n

Innovation led and generic pharma stocks give investors a way to track businesses that sit close to everyday demand in India. Glenmark Pharmaceuticals, JB Chemicals and Pharmaceuticals and Strides Pharma Science cover a research led drug maker, a branded formulations company and a finished dosage generics manufacturer.<\/p>\n

This list covers three innovation led and generic pharma stocks with complete current figures: Glenmark Pharmaceuticals, JB Chemicals and Pharmaceuticals and Strides Pharma Science. Every figure comes from the latest reported financials and the 27 October 2026 market close. Companies without complete current figures were left out.<\/p>\n

Click Here – Get Free Investment Predictions<\/a><\/strong><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n